Clinical Trial Update: Pilot Immunotherapy Trial for Recurrent Malignant Gliomas [Phase 1]

View source ↗

Summary

A Phase 1 pilot immunotherapy trial for recurrent malignant gliomas has completed (status COMPLETED).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Malignant Glioma of Brain | Phase 1 | Status: COMPLETED